Treffer 1 - 2 von 2 für Suche 'Bravo Montenegro, Gabriela L', Suchdauer: 0,24s Treffer weiter einschränken
  1. 1
    Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report

    Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report von Wilgucki, Molly, Yeung, Vincent, Ho, Grace, Bravo Montenegro, Gabriela L., Jones, Greg, Reuss, Joshua E., Liu, Stephen V., Kim, Chul


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report

    Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report von Wilgucki, Molly, Yeung, Vincent, Ho, Grace, Bravo Montenegro, Gabriela L, Jones, Greg, Reuss, Joshua E, Liu, Stephen V, Kim, Chul


    Volltext
    Report

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: